Takuya Osada

5PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 11, 2022
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity.

Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang

|Sep 28, 2022
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers.

Kensuke Kaneko, Chaitanya R Acharya, Hiroshi Nagata

|Jan 18, 2022
Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.

Shinya Abe, Hiroshi Nagata, Erika J Crosby

|Oct 22, 2021
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study.

Takuya Osada, Erika J Crosby, Kensuke Kaneko

|Feb 17, 2021
Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy.

Melinda L Telli, Hiroshi Nagata, Irene Wapnir

Pageof 1

Frequent Collaborators

5 joint publications

Herbert Kim Lyerly

4 joint publications

Chaitanya R Acharya

3 joint publications

Erika J Crosby

2 joint publications

Kensuke Kaneko